In 2025, market in the UK accounted for USD 20.74 billion.
Industry forecasts indicate the UK Infusion Services Market will attain USD 38.75 billion by 2033, yielding a CAGR of 8.1% during the forecast interval.
NHS-led central procurement and cancer care prioritization sustain infusion volumes, though budget discipline limits rapid expansion of standalone private infusion networks.
NHS England cancer activity reporting shows continued systemic therapy delivery growth, reinforcing oncology infusion demand across regional trusts.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]